HCA Healthcare Stock Drops 3.95% Despite Record Revenue and 72nd Rank in Trading Volume

On April 25, 2025, HCA Healthcare (HCA) experienced a decline of 3.95% in its stock price, with a trading volume of $924 million, ranking 72nd in the day's market activity.

HCA Healthcare reported its first-quarter 2025 financial results, with revenues totaling $18.321 billion, marking a significant increase from $17.339 billion in the same period last year. The company's net income also showed a slight improvement, reflecting a strong performance in the quarter.

HCA Healthcare's adjusted earnings per share (EPS) for the first quarter of 2025 were $6.45, surpassing the consensus estimate of $5.77. This positive earnings report was driven by a 5.7% year-over-year increase in revenue, which reached $18.32 billion. The company also reported increases in same facility admissions and equivalent admissions, both growing by 2.6% and 2.8% respectively.

Looking ahead, HCA Healthcare has reaffirmed its earnings guidance for the full year 2025, with adjusted EPS expected to be between $24.05 and $25.85, and revenues projected to be in the range of $72.8 billion. This guidance aligns with market expectations, indicating the company's confidence in its future performance.